Author

Wenzhi Deng

h-index 2 View on Semantic Scholar

We have 3 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

METTL3-mediated m6A modification of RBM39 promotes cancer stemness and tumor progression in head and neck squamous cell carcinoma

Pan-cancer analysis showed that RBM39 is aberrantly expressed in multiple cancers and is significantly associated with patient prognosis, suggesting its diagnostic value, and RBM39 may serve as a potential diagnostic and therapeutic target for HNSC.

Yu Xin, Wen-Zhi Deng, Chu-Yang Jiang et al. · Discover Oncology · 0 citations

Review Open access Jul 2026

RNA epitranscriptomic regulation of tumor immune evasion: mechanisms, context-dependent roles, and therapeutic implications

Clinical translation remains limited by insufficient specificity, tumor heterogeneity, complex crosstalk among RNA modifications, potential toxicity, and delivery barriers, so future studies integrating RNA modification mapping with single-cell, spatial, and multi-omics technologies will be essential to define cell-typ...

Yan-Ni Ma, Wen-Zhi Deng, Xiu-Lin Jiang et al. · Frontiers in Immunology · 0 citations

Review Open access Jul 2026

Primary and acquired resistance to immunotherapy in NSCLC

This review summarizes immune resistance in NSCLC through a framework that distinguishes primary resistance from acquired resistance, and discusses mechanism-based biomarkers, translational correlates, and rational therapeutic strategies for overcoming resistance.

Bo Yuan, Wenzhi Deng, Juan Luo et al. · Frontiers in Immunology · 0 citations